Drug · DIN 02569728
BESREMI
SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 14, 2026; first marketed September 14, 2026.
- Drug Identification Number (DIN)
- 02569728
- Company (DIN owner)
- Forus Therapeutics IncOakville, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Ropeginterferon alfa-2b L03AB15
- Class
- Human
- Record last updated
- September 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ROPEGINTERFERON ALFA-2B | 500 MCG | 1 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 2, 2026: NOC 37818New Drug Submission (NDS)